These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28181670)

  • 1. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
    Munro A; Leung Y; Spilsbury K; Stewart CJ; Semmens J; Codde J; Williams V; O'Leary P; Steel N; Cohen P
    Gynecol Oncol; 2015 May; 137(2):258-63. PubMed ID: 25769659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
    Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
    Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.
    Cohen PA; Brand A; Sykes P; Wrede DCH; McNally O; Eva L; Rao A; Campion M; Stockler M; Powell A; Codde J; Bulsara MK; Anderson L; Leung Y; Farrell L; Stoyles P
    BMJ Open; 2017 Aug; 7(8):e017576. PubMed ID: 28851799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    Jiang Y; Chen C; Li L
    PLoS One; 2017; 12(1):e0170587. PubMed ID: 28125627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
    Huang SS; Sui L; Chen LM; Zhang HW; Tao X
    Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
    Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
    Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.
    Codde E; Munro A; Stewart C; Spilsbury K; Bowen S; Codde J; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Cohen PA
    BJOG; 2018 Jan; 125(1):74-79. PubMed ID: 28678394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.
    Munro A; Codde J; Spilsbury K; Steel N; Stewart CJ; Salfinger SG; Tan J; Mohan GR; Leung Y; Semmens JB; O'Leary P; Williams V; Cohen PA
    Am J Obstet Gynecol; 2017 Mar; 216(3):272.e1-272.e7. PubMed ID: 27908632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
    Tan JHJ; Malloy MJ; Thangamani R; Gertig D; Drennan KT; Wrede CD; Saville M; Quinn M
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):123-129. PubMed ID: 31578727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
    Latif NA; Neubauer NL; Helenowski IB; Lurain JR
    J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy.
    Cohen PA; Leung Y; Anderson L; van der Griend R; Chivers P; Bilic S; Bittinger S; Brand A; Bulsara MK; Codde J; Eva L; Farrell L; Harker D; Herbst U; Jeffares S; Loh D; McNally O; Mohan GR; Nicholson T; Powell A; Salfinger SG; Simcock B; Stewart C; Silvers J; Stockler MR; Sykes P; Stoyles P; Tan A; Tan AL; Wrede CDH
    Gynecol Oncol; 2020 Dec; 159(3):623-629. PubMed ID: 33032824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of loop electrosurgical excisional procedure in diagnosis and treatment of cervical adenocarcinoma in situ and invasive cervical adenocarcinoma].
    Song Y; Wang Q; Sui L; Gao SJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):178-182. PubMed ID: 29609232
    [No Abstract]   [Full Text] [Related]  

  • 19. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
    van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
    Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
    Kim JH; Park JY; Kim DY; Kim YM; Kim YT; Nam JH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):100-3. PubMed ID: 19428171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.